Healthcare - Latest News, Analysis, Opinion

Healthcare Healthcare

In conversation with BusinessWorld, Dr. Praveen Gedam, Additional CEO, National Health Authority (NHA) talks about National Digital Health Mission, NHA’s progressive mission that is all set to revolutionise India’s Healthcare system.

Zydus Cadila Gets USFDA Nod For Muscle Relaxant Injection

The group now has 297 approvals and has so far filed over 390 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.

Religare Health Insurance rebrands as Care Health Insurance

Effective September 1, the rebranding is an adoption of its principal deliverable ‘Care’, the company said. Except the name, Care Health Insurance’s founding management team, value-for-money products and the technology-driven servicing capabilities are all the same, it added.

Importance And Benefits Of Drinking Purified Water For Better Immunity

Gaurav Goyal

A recent study has revealed how certain areas in hospitals contained more viruses and how an increasing number of healthcare workers themselves get infected with the deadly virus.

Moderna COVID-19 Vaccine Appears To Work As Well In Older Adults In Early Study

Health officials have been concerned about whether vaccine candidates would work in older people, whose immune systems typically do not respond as strongly to vaccines.

How Will The Current Pandemic Change The Face Of Healthcare?

Dr. Sanjeev Kanoria

COVID-19 has opened the Pandora’s Box for players with the impact clearly visible on the functioning models and financial health.

Takeda To Sell Japan Consumer Health Unit Valued At $2.3 Billion To Blackstone

Japan's largest pharmaceuticals company has been reducing its OTC assets worldwide as it seeks to refocus its business and reduce debt following its $59 billion acquisition of Shire.

Novartis Immuno-Oncology Drug Candidate Fails Skin Cancer Trial

The drug did not improve progression-free survival in previously untreated patients with BRAF V600 mutation-positive cutaneous melanoma, compared to Tafinlar + Mekinist alone, Novartis said.

India Approves Avigan (Favipiravir) for COVID-19 Treatment

In India, GRA and Dr. Reddy’s will look to distribute Avigan® through private healthcare providers opting for a premium quality drug. The initial supply will contain the original Avigan®, made in Japan.

RIL Arm Acquires Majority Stake In Online Pharmacy Netmeds For Rs 620 Cr

Rabindra Jhunjhunwala

E-pharmacies is a large market in India and the retail segment is a fragmented one, ripe for consolidation.

Dr Reddy's Laboratories Launches COVID-19 Treatment Drug In India

Dr Reddy's said Avigan has been approved by the Drugs Controller General of India (DCGI) for the treatment of patients with mild to moderate COVID-19.

Zydus Cadila Launches Generic Version Of Remdesivir At Rs 2,800 Per Vial In India

Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing.

Committee on 'How to Distribute' Covid vaccines Meets Today

An expert committee headed by NITI Aayog member VK Paul will meet on August 12 to discuss and find a road map on the procurement, distribution and the logistics of Covid-19 vaccine.

Dichotomy In The Pandemic

Kavi Bhandari